| Year |
Citation |
Score |
| 2020 |
Yamashita D, Bernstock JD, Elsayed G, Sadahiro H, Mohyeldin A, Chagoya G, Ilyas A, Mooney J, Estevez-Ordonez D, Yamaguchi S, Flanary VL, Hackney JR, Bhat KP, Kornblum HI, Zamboni N, et al. Targeting glioma-initiating cells via the tyrosine metabolic pathway. Journal of Neurosurgery. 1-12. PMID 32059178 DOI: 10.3171/2019.11.Jns192028 |
0.387 |
|
| 2019 |
Minata M, Audia A, Shi J, Lu S, Bernstock J, Pavlyukov MS, Das A, Kim SH, Shin YJ, Lee Y, Koo H, Snigdha K, Waghmare I, Guo X, Mohyeldin A, et al. Phenotypic Plasticity of Invasive Edge Glioma Stem-like Cells in Response to Ionizing Radiation. Cell Reports. 26: 1893-1905.e7. PMID 30759398 DOI: 10.1016/J.Celrep.2019.01.076 |
0.327 |
|
| 2018 |
Pavlyukov MS, Yu H, Bastola S, Minata M, Shender VO, Lee Y, Zhang S, Wang J, Komarova S, Wang J, Yamaguchi S, Alsheikh HA, Shi J, Chen D, Mohyeldin A, et al. Apoptotic Cell-Derived Extracellular Vesicles Promote Malignancy of Glioblastoma Via Intercellular Transfer of Splicing Factors. Cancer Cell. PMID 29937354 DOI: 10.1016/J.Ccell.2018.05.012 |
0.439 |
|
| 2017 |
Shah SR, David JM, Tippens ND, Mohyeldin A, Martinez-Gutierrez JC, Ganaha S, Schiapparelli P, Hamilton DH, Palena C, Levchenko A, Quiñones-Hinojosa A. Brachyury-YAP Regulatory Axis Drives Stemness and Growth in Cancer. Cell Reports. 21: 495-507. PMID 29020634 DOI: 10.1016/J.Celrep.2017.09.057 |
0.527 |
|
| 2017 |
Wang J, Cheng P, Pavlyukov MS, Yu H, Zhang Z, Kim SH, Minata M, Mohyeldin A, Xie W, Chen D, Goidts V, Frett B, Hu W, Li H, Shin YJ, et al. Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2. The Journal of Clinical Investigation. PMID 28737508 DOI: 10.1172/Jci89092 |
0.385 |
|
| 2016 |
Shah SR, Tippens N, Park J, Mohyeldin A, Vela G, Martinez-Gutierrez JC, Margolis SS, Schmidt S, Levchenko A, Quinones-Hinojosa A. 217 YAP Is Ready to Rac and Rho: Elucidation of a Novel YAP-Driven Network That Potentiates Brain Cancer Cell Dispersal and Confers Poor Survival in Patients. Neurosurgery. 63: 185. PMID 28175419 DOI: 10.1227/01.neu.0000489786.22041.2d |
0.432 |
|
| 2016 |
Cheng P, Wang J, Waghmare I, Sartini S, Coviello V, Kim S, Mohyeldin A, Pavlyukov MS, Zhang Z, Minata M, Valentim CL, Chhipa RR, Bhat KP, Dasgupta B, La Motta C, et al. FOXD1-ALDH1A3 signaling is a determinant for the self-renewal and tumorigenicity of mesenchymal glioma stem cells. Cancer Research. PMID 27569208 DOI: 10.1158/0008-5472.Can-15-2860 |
0.435 |
|
| 2016 |
Shah SR, Tippens N, Park J, Mohyeldin A, Vela G, Martinez-Gutierrez JC, Margolis SS, Schmidt S, Levchenko A, Quinones-Hinojosa A. 217 YAP Is Ready to Rac and Rho: Elucidation of a Novel YAP-Driven Network That Potentiates Brain Cancer Cell Dispersal and Confers Poor Survival in Patients. Neurosurgery. 63: 185. PMID 27399496 DOI: 10.1227/01.Neu.0000489786.22041.2D |
0.532 |
|
| 2016 |
Kim SH, Ezhilarasan R, Phillips E, Gallego-Perez D, Sparks A, Taylor D, Ladner K, Furuta T, Sabit H, Chhipa R, Cho JH, Mohyeldin A, Beck S, Kurozumi K, Kuroiwa T, et al. Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-κB-dependent Manner. Cancer Cell. 29: 201-213. PMID 26859459 DOI: 10.1016/J.Ccell.2016.01.005 |
0.334 |
|
| 2016 |
Shah S, David J, Tippens N, Mohyeldin A, Martinez JC, Ganaha S, Levchenko A, Palena C, Quinones-Hinojosa A. CSIG-05. PUTTING THE BRAKES ON BRACHYURY: IDENTIFYING AND TARGETING A CONSERVED TRANSCRIPTIONAL NETWORK THAT DRIVES PRIMARY AND METASTATIC TUMOR INITIATION AND PROPAGATION Neuro-Oncology. 18: vi41-vi41. DOI: 10.1093/Neuonc/Now212.166 |
0.32 |
|
| 2015 |
Ganguly R, Mohyeldin A, Thiel J, Kornblum HI, Beullens M, Nakano I. MELK-a conserved kinase: functions, signaling, cancer, and controversy. Clinical and Translational Medicine. 4: 11. PMID 25852826 DOI: 10.1186/S40169-014-0045-Y |
0.417 |
|
| 2014 |
Mohyeldin A, Prevedello DM, Jamshidi AO, Ditzel Filho LF, Carrau RL. Nuances in the treatment of malignant tumors of the clival and petroclival region. International Archives of Otorhinolaryngology. 18: S157-72. PMID 25992140 DOI: 10.1055/S-0034-1395267 |
0.329 |
|
| 2014 |
Shah SR, Tippens ND, Park J, Mohyeldin A, Vela G, Levchenko A, Quinones-Hinojosa A. CS-31 * A NOVEL YAP-DRIVEN MIGRATION AND INVASION SIGNALING PATHWAY PREDICTS POOR OUTCOME IN GLIOBLASTOMA Neuro-Oncology. 16: v57-v58. DOI: 10.1093/Neuonc/Nou242.31 |
0.583 |
|
| 2012 |
Hsu W, Mohyeldin A, Shah SR, Gokaslan ZL, Quinones-Hinojosa A. Role of cancer stem cells in spine tumors: review of current literature. Neurosurgery. 71: 117-25. PMID 22418583 DOI: 10.1227/Neu.0B013E3182532E71 |
0.552 |
|
| 2011 |
Hsu W, Mohyeldin A, Shah SR, ap Rhys CM, Johnson LF, Sedora-Roman NI, Kosztowski TA, Awad OA, McCarthy EF, Loeb DM, Wolinsky JP, Gokaslan ZL, Quiñones-Hinojosa A. Generation of chordoma cell line JHC7 and the identification of Brachyury as a novel molecular target. Journal of Neurosurgery. 115: 760-9. PMID 21699479 DOI: 10.3171/2011.5.Jns11185 |
0.407 |
|
| 2011 |
Sedora-Román NI, Pendleton C, Mohyeldin A, Quiñones-Hinojosa A. Harvey Cushing's early experience with pediatric gliomas. Child's Nervous System : Chns : Official Journal of the International Society For Pediatric Neurosurgery. 27: 819-24. PMID 21287180 DOI: 10.1007/S00381-011-1392-2 |
0.316 |
|
| 2010 |
Mohyeldin A, Garzón-Muvdi T, Quiñones-Hinojosa A. Oxygen in stem cell biology: a critical component of the stem cell niche. Cell Stem Cell. 7: 150-61. PMID 20682444 DOI: 10.1016/J.Stem.2010.07.007 |
0.345 |
|
| 2010 |
Halim ND, Mcfate T, Mohyeldin A, Okagaki P, Korotchkina LG, Patel MS, Jeoung NH, Harris RA, Schell MJ, Verma A. Phosphorylation status of pyruvate dehydrogenase distinguishes metabolic phenotypes of cultured rat brain astrocytes and neurons. Glia. 58: 1168-76. PMID 20544852 DOI: 10.1002/Glia.20996 |
0.449 |
|
| 2008 |
McFate T, Mohyeldin A, Lu H, Thakar J, Henriques J, Halim ND, Wu H, Schell MJ, Tsang TM, Teahan O, Zhou S, Califano JA, Jeoung NH, Harris RA, Verma A. Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells. The Journal of Biological Chemistry. 283: 22700-8. PMID 18541534 DOI: 10.1074/jbc.M801765200 |
0.577 |
|
| 2007 |
Mohyeldin A, Dalgard CL, Lu H, Mcfate T, Tait AS, Patel VC, Wong K, Rushing E, Roy S, Acs G, Verma A. Survival and invasiveness of astrocytomas promoted by erythropoietin. Journal of Neurosurgery. 106: 338-50. PMID 17410721 DOI: 10.3171/Jns.2007.106.2.338 |
0.66 |
|
| 2005 |
Lu H, Dalgard CL, Mohyeldin A, McFate T, Tait AS, Verma A. Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. The Journal of Biological Chemistry. 280: 41928-39. PMID 16223732 DOI: 10.1074/Jbc.M508718200 |
0.618 |
|
| 2005 |
McBroom JW, Acs G, Rose GS, Krivak TC, Mohyeldin A, Verma A. Erythropoietin receptor function and expression in epithelial ovarian carcinoma. Gynecologic Oncology. 99: 571-7. PMID 16051335 DOI: 10.1016/j.ygyno.2005.06.038 |
0.533 |
|
| 2005 |
Mohyeldin A, Lu H, Dalgard C, Lai SY, Cohen N, Acs G, Verma A. Erythropoietin signaling promotes invasiveness of human head and neck squamous cell carcinoma. Neoplasia (New York, N.Y.). 7: 537-43. PMID 15967106 DOI: 10.1593/Neo.04685 |
0.661 |
|
| 2004 |
Dalgard CL, Lu H, Mohyeldin A, Verma A. Endogenous 2-oxoacids differentially regulate expression of oxygen sensors. The Biochemical Journal. 380: 419-24. PMID 14984367 DOI: 10.1042/Bj20031647 |
0.61 |
|
| 2003 |
Acs G, Zhang PJ, McGrath CM, Acs P, McBroom J, Mohyeldin A, Liu S, Lu H, Verma A. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. The American Journal of Pathology. 162: 1789-806. PMID 12759237 DOI: 10.1016/S0002-9440(10)64314-3 |
0.553 |
|
| Show low-probability matches. |